Cargando…
Impact of Different Cell Counting Methods in Molecular Monitoring of Chronic Myeloid Leukemia Patients
Background: Detection of BCR-ABL1 transcript level via real-time quantitative-polymerase-chain reaction (Q-PCR) is a clinical routine for disease monitoring, assessing Tyrosine Kinase Inhibitor therapy efficacy and predicting long-term response in chronic myeloid leukemia (CML) patients. For valid Q...
Autores principales: | Stella, Stefania, Vitale, Silvia Rita, Stagno, Fabio, Massimino, Michele, Puma, Adriana, Tomarchio, Cristina, Pennisi, Maria Stella, Tirrò, Elena, Romano, Chiara, Di Raimondo, Francesco, Cacciola, Emma, Cacciola, Rossella, Manzella, Livia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9140187/ https://www.ncbi.nlm.nih.gov/pubmed/35626209 http://dx.doi.org/10.3390/diagnostics12051051 |
Ejemplares similares
-
A Novel System for Semiautomatic Sample Processing in Chronic Myeloid Leukaemia: Increasing Throughput without Impacting on Molecular Monitoring at Time of SARS-CoV-2 Pandemic
por: Stella, Stefania, et al.
Publicado: (2021) -
Non ABL-directed inhibitors as alternative treatment strategies for chronic myeloid leukemia
por: Massimino, Michele, et al.
Publicado: (2018) -
High BCR::ABL1 Expression Defines CD34+ Cells with Significant Alterations in Signal Transduction, Short-Proliferative Potential and Self-Renewal Ability
por: Massimino, Michele, et al.
Publicado: (2023) -
Opportunities and Challenges of Liquid Biopsy in Thyroid Cancer
por: Romano, Chiara, et al.
Publicado: (2021) -
Impact of the Breakpoint Region on the Leukemogenic Potential and the TKI Responsiveness of Atypical BCR-ABL1 Transcripts
por: Massimino, Michele, et al.
Publicado: (2021)